Submissions for variant NM_024675.4(PALB2):c.212-24TA[4]

dbSNP: rs751741705

Total submissions: 7

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Counsyl	RCV000410697	SCV000489507	likely benign	Familial cancer of breast	2016-10-13	criteria provided, single submitter	clinical testing
Color Diagnostics, LLC DBA Color Health	RCV000583383	SCV000690829	likely benign	Hereditary cancer-predisposing syndrome	2015-04-16	criteria provided, single submitter	clinical testing
PreventionGenetics, part of Exact Sciences	RCV000679763	SCV000807085	likely benign	not provided	2017-03-17	criteria provided, single submitter	clinical testing
GeneDx	RCV000679763	SCV001860735	benign	not provided	2015-03-06	criteria provided, single submitter	clinical testing
Labcorp Genetics (formerly Invitae), Labcorp	RCV000410697	SCV002416674	benign	Familial cancer of breast	2025-01-23	criteria provided, single submitter	clinical testing
Fulgent Genetics, Fulgent Genetics	RCV002502438	SCV002808123	likely benign	Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3	2022-01-07	criteria provided, single submitter	clinical testing
Myriad Genetics, Inc.	RCV000410697	SCV004019175	benign	Familial cancer of breast	2023-03-30	criteria provided, single submitter	clinical testing	This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing.